Top 20 Global Chemical Companies by Revenue in 2025

Dow Inc. announced its fourth-quarter and full-year 2025 financial results. Q4 net sales totaled $9.46 billion, down from $10.405 billion in the prior-year quarter. Net loss attributable to common shareholders for the quarter was $1.543 billion, compared to a net loss of $53 million in the prior-year quarter. Full-year net sales amounted to $39.968 billion, down from $42.964 billion in the prior year. Full-year net loss attributable to common shareholders was $2.623 billion, versus net income of $1.116 billion in the prior year. Ecolab Inc. announced its fourth-quarter and full-year 2025 financial results. Q4 net sales totaled $4.196 billion, up 5% year-on-year from $4.005 billion. Operating profit for the quarter was $712 million, up 22% from $583 million in the prior-year quarter. Net income attributable to the company was $564 million, up 19% from $473 million in the prior-year quarter. Full-year net sales were $16.081 billion, up 2% from $15.741 billion in the prior year. Full-year operating profit was $2.738 billion, down 2% from $2.802 billion in the prior year. Full-year net income attributable to the company was $2.076 billion, down 2% from $2.112 billion in the prior year. Westlake Corporation announced its fourth-quarter and full-year 2025 financial results. Q4 net sales totaled $2.533 billion, down from $2.843 billion in the prior-year quarter. Net loss attributable to the company for the quarter was $544 million, versus a net loss of $782 million in the prior-year quarter. Full-year net sales were $11.17 billion, down from $12.142 billion in the prior year. Full-year net loss attributable to the company was $1.508 billion, versus net income of $602 million in the prior year. International Flavors & Fragrances Inc. (IFF) announced its fourth-quarter and full-year 2025 financial results. Q4 net sales totaled $2.589 billion, down 7% year-on-year from $2.771 billion. Operating profit for the quarter was $97 million, down 24% from $127 million in the prior-year quarter. Net income attributable to shareholders was $18 million, versus a net loss of $60 million in the prior-year quarter. Full-year net sales were $10.89 billion, down 5% from $11.184 billion in the prior year. Full-year operating loss was $382 million, versus operating income of $766 million in the prior year. Full-year net loss attributable to shareholders was $374 million, versus net income of $263 million in the prior year. Celanese Corporation announced its fourth-quarter and full-year 2025 financial results. Q4 net sales totaled $2.204 billion, down from $2.358 billion in the prior-year quarter. Operating profit for the quarter was $93 million, versus an operating loss of $1.419 billion in the prior-year quarter. Net income for the quarter was $22 million, versus a net loss of $1.922 billion in the prior-year quarter. Full-year net sales were $9.544 billion, down from $10.268 billion in the prior year. Full-year operating loss was $786 million, versus an operating loss of $720 million in the prior year. Full-year net loss was $1.151 billion, versus a net loss of $1.534 billion in the prior year.

Net profit fell by as much as 22%—international raw material suppliers’ business is ‘tough’!

IFF stated that growth in this segment’s performance benefited from higher product volumes, rising raw material prices, and improved productivity. DSM-Firmenich’s Fragrance & Beauty division reported a 2.2% year-on-year decline in sales in 2023, while adjusted EBITDA rose 4.7% year-on-year. Specifically, sales across all sub-segments posted growth: organic sales in the fragrance business rose 1%; consumer flavors sales surged rapidly in Q2 due to innovation and expansion in product portfolios; and personal care sales increased, driven by heightened demand for sun protection, skincare, and haircare products. Regarding the Fragrance & Beauty division’s sales decline, DSM-Firmenich noted in its earnings report that the overall drop stemmed from raw material destocking, weak industrial demand, and the closure of Pinova’s Georgia (U.S.) facility. –4.1%, –12.1%: Givaudan’s Asia-Pacific and North America regions both declined. By region, the performance of three major flavor & fragrance companies in the Asia-Pacific/China market was underwhelming: DSM-Firmenich posted 24.2% growth in China, whereas Givaudan’s Asia-Pacific region declined by 4.1%. In 2023, Givaudan’s sales declined in both North America and the Asia-Pacific region, while Latin America and EAME (Europe, Africa, Middle East) posted gains. Specifically, Givaudan’s Asia-Pacific sales totaled CHF 1.698 billion (approx. RMB 13.882 billion), down 4.1% year-on-year. Its North American sales declined 12.1%, while Latin America and EAME rose 1.1% and 3.4%, respectively. DSM-Firmenich reported sales growth in Switzerland, the Netherlands, the rest of EMEA, North America, Latin America, China, and other Asian markets in 2023. Specifically, DSM-Firmenich’s 2023 sales in China reached €997 million (approx. RMB 7.773 billion), up 24.2% year-on-year. DSM-Firmenich disclosed that, beginning mid-2023, it launched a restructuring plan for its vitamins business to reduce costs and improve efficiency, thereby restoring profitability. In China, DSM-Firmenich advanced this initiative by closing its Shanghai Xinghuo vitamin B6 plant and Jiangshan vitamin C plant. Persistent performance pressure and the ‘failure’ of pricing strategies—the industry’s self-rescue efforts Overall, although the 2023 financial results of these three major international flavor & fragrance companies declined, their flavor & fragrance businesses tied to the cosmetics industry generally posted growth. Analyzing the causes behind the earnings declines based on their financial reports, key factors include intense market competition, rising raw material prices, supply chain disruptions, and pandemic-related impacts. For instance, Givaudan noted in its 2023 semi-annual report that, amid increasing input costs, it would continue implementing price increases to offset those costs—factors such as maintaining operational and supply chain stability contributed to cost inflation. Facing persistent performance pressure and the ‘failure’ of pricing strategies, international flavor & fragrance companies have adopted multiple measures for self-rescue. — Expansion into overseas markets In recent years, numerous international flavor & fragrance giants have expanded into the Greater China region, establishing manufacturing facilities, partnering with Chinese brands and enterprises, and appointing executives with deep expertise in the Chinese market—all aimed at deeper localization.

International Flavors & Fragrances, Inc. Estimates – NYSE:IFF

Oct 23, 2026

TradingView provides an overview of financial estimates and actuals for International Flavors & Fragrances, Inc. (NYSE:IFF), allowing users to compare reported data with analyst expectations over time.

TradingView

2026-04-07

BNP Paribas Exane Lowers Price Target for International Flavors & Fragrances (NYSE:IFF)

2026-04-07

International Flavors & Fragrances Inc. Stock Underperforms on Tuesday

2026-04-08

International Flavors & Fragrances Inc. Given Consensus Recommendation of "Moderate Buy" by Analysts

2026-04-09

OFI Invest Asset Management Reduces Stake in International Flavors & Fragrances

2026-04-10

Douglas Lane & Associates LLC Sells 39,607 Shares of International Flavors & Fragrances Inc.